KYNB KYNTRA BIO, INC.: institutional ownership and insider trading
33 funds reported holding $9.96M of KYNTRA BIO, INC. in their latest 13F filings; in Q2 2026 funds net sold $270K, with 1 new positions and 5 funds selling out; over the last 12 months insiders bought $53.6K and sold $0 on the open market.
Famous investors holding KYNB
- Two Sigma (Two Sigma Investments): $298K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $204K, 0.0% of the portfolio
Largest institutional holders of KYNB
- ARMISTICE CAPITAL, LLC — $3.02M
- VANGUARD GROUP INC — $1.60M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.21M
- ACADIAN ASSET MANAGEMENT LLC — $795K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $675K
- BlackRock, Inc. (BLK) — $637K
- GEODE CAPITAL MANAGEMENT, LLC — $326K
- HighTower Advisors, LLC — $300K
- TWO SIGMA INVESTMENTS, LP — $298K
- RENAISSANCE TECHNOLOGIES LLC — $204K
Recent KYNB insider trades
- May 14, 2026: Wettig Thane bought 2,800 shares ($19.9K)
- Nov 17, 2025: Wettig Thane bought 3,700 shares ($33.8K)
- Jun 30, 2025: Schoeneck James A bought 23,567 shares ($119K)
- Mar 24, 2025: Wettig Thane bought 145,000 shares ($50.8K)
5%+ owners
- Armistice Capital, LLC: 9.9% (Schedule 13G/A, filed Aug 14, 2026)